Antipsychotic drugs in bipolar disorder

Aygun Ertugrul, Herbert Y. Meltzer*

*Corresponding author for this work

Research output: Contribution to journalReview article

31 Citations (Scopus)

Abstract

Antipsychotic drugs are useful in the treatment of acute mania and as maintenance treatment. While both typical and atypical antipsychotic drugs are able to diminish manic symptoms, agitation and aggression in acute mania, the atypical antipsychotic drugs enjoy a number of advantages, including significantly less extrapyramidal symptoms, diminished risk of tardive dyskinesia, lack of increase in serum prolactin levels (with the exception of risperidone), improvement in cognition, and possible decrease in suicidality. Most of the atypical antipsychotic drugs have been found to be effective as an add-on treatment (with mood stabilizers and antidepressant drugs) and sometimes as monotherapy in treatment-resistant bipolar patients. Long-acting typical neuroleptic drugs may be useful in the treatment of non-compliant bipolar patients. A small number of patients with schizophrenia treated with risperidone, olanzapine, or quetiapine experience a first episode of hypomania or mania. It is not apparent if this is a true drug-induced event or coincidental. Side-effects of note with the atypical antipsychotic drugs are weight gain (most prominently with olanzapine and clozapine), sedation, and agranulocytosis (clozapine). Atypical antipsychotic drugs are recommended for use in bipolar disorder for acute treatment, maintenance treatment, and for treatment-resistant patients.

Original languageEnglish (US)
Pages (from-to)277-284
Number of pages8
JournalInternational Journal of Neuropsychopharmacology
Volume6
Issue number3
DOIs
StatePublished - Sep 1 2003

Fingerprint

Bipolar Disorder
Antipsychotic Agents
olanzapine
Risperidone
Clozapine
Therapeutics
Agranulocytosis
Aggression
Prolactin
Cognition
Antidepressive Agents
Weight Gain
Schizophrenia
Serum
Pharmaceutical Preparations

Keywords

  • Antipsychotic drugs
  • Bipolar disorder
  • Mania

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

@article{7ec03d9955004a3c9ae7544512371be4,
title = "Antipsychotic drugs in bipolar disorder",
abstract = "Antipsychotic drugs are useful in the treatment of acute mania and as maintenance treatment. While both typical and atypical antipsychotic drugs are able to diminish manic symptoms, agitation and aggression in acute mania, the atypical antipsychotic drugs enjoy a number of advantages, including significantly less extrapyramidal symptoms, diminished risk of tardive dyskinesia, lack of increase in serum prolactin levels (with the exception of risperidone), improvement in cognition, and possible decrease in suicidality. Most of the atypical antipsychotic drugs have been found to be effective as an add-on treatment (with mood stabilizers and antidepressant drugs) and sometimes as monotherapy in treatment-resistant bipolar patients. Long-acting typical neuroleptic drugs may be useful in the treatment of non-compliant bipolar patients. A small number of patients with schizophrenia treated with risperidone, olanzapine, or quetiapine experience a first episode of hypomania or mania. It is not apparent if this is a true drug-induced event or coincidental. Side-effects of note with the atypical antipsychotic drugs are weight gain (most prominently with olanzapine and clozapine), sedation, and agranulocytosis (clozapine). Atypical antipsychotic drugs are recommended for use in bipolar disorder for acute treatment, maintenance treatment, and for treatment-resistant patients.",
keywords = "Antipsychotic drugs, Bipolar disorder, Mania",
author = "Aygun Ertugrul and Meltzer, {Herbert Y.}",
year = "2003",
month = "9",
day = "1",
doi = "10.1017/S1461145703003560",
language = "English (US)",
volume = "6",
pages = "277--284",
journal = "International Journal of Neuropsychopharmacology",
issn = "1461-1457",
publisher = "Cambridge University Press",
number = "3",

}

Antipsychotic drugs in bipolar disorder. / Ertugrul, Aygun; Meltzer, Herbert Y.

In: International Journal of Neuropsychopharmacology, Vol. 6, No. 3, 01.09.2003, p. 277-284.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Antipsychotic drugs in bipolar disorder

AU - Ertugrul, Aygun

AU - Meltzer, Herbert Y.

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Antipsychotic drugs are useful in the treatment of acute mania and as maintenance treatment. While both typical and atypical antipsychotic drugs are able to diminish manic symptoms, agitation and aggression in acute mania, the atypical antipsychotic drugs enjoy a number of advantages, including significantly less extrapyramidal symptoms, diminished risk of tardive dyskinesia, lack of increase in serum prolactin levels (with the exception of risperidone), improvement in cognition, and possible decrease in suicidality. Most of the atypical antipsychotic drugs have been found to be effective as an add-on treatment (with mood stabilizers and antidepressant drugs) and sometimes as monotherapy in treatment-resistant bipolar patients. Long-acting typical neuroleptic drugs may be useful in the treatment of non-compliant bipolar patients. A small number of patients with schizophrenia treated with risperidone, olanzapine, or quetiapine experience a first episode of hypomania or mania. It is not apparent if this is a true drug-induced event or coincidental. Side-effects of note with the atypical antipsychotic drugs are weight gain (most prominently with olanzapine and clozapine), sedation, and agranulocytosis (clozapine). Atypical antipsychotic drugs are recommended for use in bipolar disorder for acute treatment, maintenance treatment, and for treatment-resistant patients.

AB - Antipsychotic drugs are useful in the treatment of acute mania and as maintenance treatment. While both typical and atypical antipsychotic drugs are able to diminish manic symptoms, agitation and aggression in acute mania, the atypical antipsychotic drugs enjoy a number of advantages, including significantly less extrapyramidal symptoms, diminished risk of tardive dyskinesia, lack of increase in serum prolactin levels (with the exception of risperidone), improvement in cognition, and possible decrease in suicidality. Most of the atypical antipsychotic drugs have been found to be effective as an add-on treatment (with mood stabilizers and antidepressant drugs) and sometimes as monotherapy in treatment-resistant bipolar patients. Long-acting typical neuroleptic drugs may be useful in the treatment of non-compliant bipolar patients. A small number of patients with schizophrenia treated with risperidone, olanzapine, or quetiapine experience a first episode of hypomania or mania. It is not apparent if this is a true drug-induced event or coincidental. Side-effects of note with the atypical antipsychotic drugs are weight gain (most prominently with olanzapine and clozapine), sedation, and agranulocytosis (clozapine). Atypical antipsychotic drugs are recommended for use in bipolar disorder for acute treatment, maintenance treatment, and for treatment-resistant patients.

KW - Antipsychotic drugs

KW - Bipolar disorder

KW - Mania

UR - http://www.scopus.com/inward/record.url?scp=0141996409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141996409&partnerID=8YFLogxK

U2 - 10.1017/S1461145703003560

DO - 10.1017/S1461145703003560

M3 - Review article

C2 - 12974994

AN - SCOPUS:0141996409

VL - 6

SP - 277

EP - 284

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

SN - 1461-1457

IS - 3

ER -